Skip to main content
OpenTrials

Clinical trial condition

Amyloidosis

Explore clinical trials studying Amyloidosis. Study availability and eligibility vary by location and protocol.

96 public trials 27 recruiting studies
Refine in advanced search Browse all conditions

Amyloidosis trial results

Recruiting

Pan-Amyloid PET/CT in Various Amyloid-Related Disease

NCT07130565

Conditions
Alzheimer Disease, Amyloid, Amyloid Neuropathies, +21 more
Locations
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

[18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis

NCT07232459

Conditions
Alzheimer Disease, Amyloid, Amyloid Neuropathies, +22 more
Locations
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • Tianjin Medical University General Hospital Tianjin, Tianjin Municipality, China
  • The Affiliated Hospital of Qingdao University Qingdao, Shandong, China
View Trial Details
Recruiting

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

NCT06563895

Conditions
Alzheimer Disease, Amyloid Cardiomyopathy, Amyloid Neuropathies, +26 more
Locations
  • University of California, San Diego (UCSD) - Medical Center La Jolla, California, United States
  • University of California, Los Angeles (UCLA) - David Geffen School of Medicine Los Angeles, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Stanford University Stanford, California, United States
View all 104 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Belantamab Mafodotin in Combination With Cyclophosphamide, Bortezomib, and Dexamethasone in Adult Participants With Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis

NCT07224672

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +9 more
Locations
  • GSK Investigational Site Rochester, Minnesota, United States
  • GSK Investigational Site Westmead, New South Wales, Australia
  • GSK Investigational Site Woolloongabba, Queensland, Australia
  • GSK Investigational Site Box Hill, Victoria, Australia
View Trial Details

Related conditions